Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Internist (Berl) ; 62(1): 111-120, 2021 Jan.
Article in German | MEDLINE | ID: mdl-33349899

ABSTRACT

This consensus paper summarizes the expert consensus and recommendations of the working group "Heart and Kidney" of the German Cardiac Society (DGK) and the German Society of Nephrology (DGfN) on contrast medium-induced acute kidney injury. Potentially nephrotoxic contrast agents containing iodine are frequently used in interventional medicine and for computer tomography diagnostics. Acute kidney injury occurs in approximately 8-17% of patients exposed to contrast media. The risk factors and underlying pathophysiology are discussed and recommendations for the prophylaxis and treatment of contrast medium-induced acute nephropathy are presented.


Subject(s)
Acute Kidney Injury/chemically induced , Contrast Media/toxicity , Kidney/metabolism , Nephrology/standards , Practice Guidelines as Topic/standards , Acute Kidney Injury/diagnosis , Acute Kidney Injury/prevention & control , Consensus , Contrast Media/administration & dosage , Humans , Risk Factors , Societies, Medical
2.
Infection ; 43(1): 83-7, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25380569

ABSTRACT

Nephropathia epidemica is a milder form of hemorrhagic fever with renal syndrome, caused by Puumala virus. The clinical picture is characterized by a rapid loss of renal function (acute kidney injury) and thrombocytopenia. The purpose of the current analysis was to compare the clinical course of patients presenting with or without severe thrombocytopenia. In 47 out of 456 patients with acute nephropathia epidemica, the nadir count of thrombocytes was available for the acute course of the disease. The clinical course of these patients was further analyzed. No major bleeding (e.g., intracranial bleeding or gastrointestinal bleeding) occurred in either group. Creatinine peak levels were higher and proteinuria was more frequently present in the severely thrombocytopenic group. In conclusion, severe thrombocytopenia is common in nephropathia epidemica and is associated with a more severe course of the disease; however, bleeding complications are rare.


Subject(s)
Hemorrhagic Fever with Renal Syndrome/complications , Hemorrhagic Fever with Renal Syndrome/epidemiology , Orthohantavirus , Thrombocytopenia/epidemiology , Thrombocytopenia/etiology , Adult , Aged , Female , Germany/epidemiology , Humans , Male , Middle Aged , Puumala virus , Retrospective Studies
3.
Ann Rheum Dis ; 73(9): 1742-5, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24919468

ABSTRACT

OBJECTIVE: Different lines of evidence have highlighted the role of IL-17A in the inflammatory process occurring in giant cell arteritis (GCA). The aim of the present study was to assess whether the IL17A locus influences GCA susceptibility and its clinical subphenotypes. METHODS: We carried out a large meta-analysis including a total of 1266 biopsy-proven GCA patients and 3779 healthy controls from four European populations (Spain, Italy, Germany and Norway). Five IL17A polymorphisms (rs4711998, rs8193036, rs3819024, rs2275913 and rs7747909) were selected by tagging and genotyped using TaqMan assays. Allelic combination and dependency tests were also performed. RESULTS: In the pooled analysis, two of the five analysed polymorphisms showed evidence of association with GCA (rs2275913: PMH=1.85E-03, OR=1.17 (1.06-1.29); rs7747909: PMH=8.49E-03, OR=1.15 (1.04-1.27)). A clear trend of association was also found for the rs4711998 variant (PMH=0.059, OR=1.11 (1.00-1.23)). An independent effect of rs2275913 and rs4711998 was evident by conditional regression analysis. In addition, the haplotype harbouring the risk alleles better explained the observed association than the polymorphisms independently (likelihood p value <10(-05)). CONCLUSIONS: Polymorphisms within the IL17A locus show a novel association with GCA. This finding supports the relevant role of the Th17 cells in this vasculitis pathophysiology.


Subject(s)
Giant Cell Arteritis/genetics , Interleukin-17/genetics , Case-Control Studies , Gene Frequency , Genetic Predisposition to Disease , Genotype , Haplotypes , Humans , Polymorphism, Genetic
4.
Ann Rheum Dis ; 72(11): 1882-1886, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23946333

ABSTRACT

OBJECTIVE: To analyse the role of the PTPN22 and CSK genes, previously associated with autoimmunity, in the predisposition and clinical phenotypes of giant cell arteritis (GCA). METHODS: Our study population was composed of 911 patients diagnosed with biopsy-proven GCA and 8136 unaffected controls from a Spanish discovery cohort and three additional independent replication cohorts from Germany, Norway and the UK. Two functional PTPN22 polymorphisms (rs2476601/R620W and rs33996649/R263Q) and two variants of the CSK gene (rs1378942 and rs34933034) were genotyped using predesigned TaqMan assays. RESULTS: The analysis of the discovery cohort provided evidence of association of PTPN22 rs2476601/R620W with GCA (PFDR=1.06E-04, OR=1.62, CI 95% 1.29 to 2.04). The association did not appear to follow a specific GCA subphenotype. No statistically significant differences between allele frequencies for the other PTPN22 and CSK genetic variants were evident either in the case/control or in stratified case analysis. To confirm the detected PTPN22 association, three replication cohorts were genotyped, and a consistent association between the PTPN22 rs2476601/R620W variant and GCA was evident in the overall meta-analysis (PMH=2.00E-06, OR=1.51, CI 95% 1.28 to 1.79). CONCLUSIONS: Our results suggest that the PTPN22 polymorphism rs2476601/R620W plays an important role in the genetic risk to GCA.


Subject(s)
Giant Cell Arteritis/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 22/genetics , src-Family Kinases/genetics , CSK Tyrosine-Protein Kinase , Case-Control Studies , Cohort Studies , Gene Frequency , Genetic Predisposition to Disease , Humans , Polymorphism, Genetic , Polymorphism, Single Nucleotide , Real-Time Polymerase Chain Reaction
6.
Minerva Urol Nefrol ; 64(2): 149-52, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22617309

ABSTRACT

We present a the case of 58-year old man who was admitted to hospital with typical clinical features (bloody nasal discharge, arthralgia, acute kidney injury with a nephritic syndrome) consisting with Wegeners granulomatosis (WG). CT-scan showed pulmonary nodules and antineutrophil cytoplasmatic antibodies (ANCA) were elevated. A kidney biopsy showed a crescentic glomerulonephritis, but not pauci-immune-immune with a histopathological staining of a mesangioproliferative IgA-glomerulonephritis. The patient was put on prednisolone and i.v. cyclophosphamid (CYCLOPS-protocol (1). The anti-proteinase-3 antibody titer decreased and the CT-scan showed decreased activity of Wegener's granulomatosis (BVAS 26 dropped to 2) and the patient`s serum creatinine level was stable. The exact nosological relation of mesangial IgA-nephropathy to WG is still unclear. This case underlines that knowledge of renal histology is essential in the management of patients with renal disease, especially in patients with hematuria and/or proeinuria with positive ANCA.


Subject(s)
Antibodies, Antineutrophil Cytoplasmic/blood , Glomerulonephritis, IGA/diagnosis , Glomerulonephritis, IGA/immunology , Granulomatosis with Polyangiitis/diagnosis , Granulomatosis with Polyangiitis/immunology , Immunoglobulin A/blood , Immunologic Factors/blood , Biomarkers/blood , Cyclophosphamide/therapeutic use , Drug Therapy, Combination , Follow-Up Studies , Glomerulonephritis, IGA/blood , Glomerulonephritis, IGA/drug therapy , Glucocorticoids/therapeutic use , Granulomatosis with Polyangiitis/blood , Granulomatosis with Polyangiitis/drug therapy , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Prednisolone/therapeutic use , Tomography, X-Ray Computed , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...